A method wherein small, two- or three-dimensional structures are formed by multiple-photon-absorbed photopolymerization and/or cross-linking of a precursor composition. Use of multi-photon excitation allows fabrication of structures and structural features having at least one dimension of less than about one micron, preferably less than about 500 nm, more preferably less than about 250 nm, and most preferably of less than about 100 nm, in bulk phase as well as in solution, and from a wide variety of organic and inorganic precursor subunits, including synthetic polymers and biological polymers such as proteins, lipids, oligonucleotides, and the like. In one embodiment, use of two-photon far field optics allows the formation of structures having X-Y dimensions of less than about 300 nm and a Z dimension of less than about 500 nm, while use of three-photon far field optics allows the formation of structures having X-Y dimensions of less than about 250 nm and a Z dimension of less than about 300 nm. In a particularly preferred embodiment, use of a 4 pi optical configuration in combination with two-photon far field excitation allows the formation of structures having X-Y dimensions of less than about 150 nm and a Z dimension of less than about 100 nm. In another embodiment, use of multi-photon near field optics results in the formation of structures having X, Y, and Z dimensions of less than about 50 nm. In this embodiment, near field fabrication is achieved by two-photon excitation through fiber probes.
|
1. A multi-photon excitation system for activating a photoactivable precursor composition, the system comprising:
a photon source generating a beam of photons, each photon having a wavelength approximately equal to an integer multiple of the wavelength necessary for single photon excitation in a photoactivatable precursor composition comprising at least two entities selected from the group consisting of proteins, peptides, nucleic acids, bioactive molecules and synthetic polymers; wherein the at least two entities may be the same or different; an optical system for directing the beam of photons to a focal point in at least one first location in the precursor composition; a mechanism for causing relative motion in a prescribed coordinate system between the precursor composition and the photon beam; and a controller for controlling the relative motion between the precursor composition and the photon beam.
2. The multi-photon excitation system as set forth in
3. The multi-photon excitation system as set forth in
4. The multi-photon excitation system as set forth in
a first laser generating the photon beam; and a pump laser providing pump energy to the first laser.
5. The multi-photon excitation system as set forth in
6. The multi-photon excitation system as set forth in
7. The multi-photon excitation system as set forth in
8. The multi-photon excitation system as set forth in
9. The multi-photon excitation system as set forth in
10. The multi-photon excitation system as set forth in
11. The multi-photon excitation system as set forth in
12. The multi-photon excitation system as set forth in
a beam splitter for splitting the photon beam into a first beam and a second beam; means for directing the first beam and the second beam to the precursor composition along separate pathways.
13. The multi-photon excitation system as set forth in
14. The multi-photon excitation system as set forth in
a first lens system receptive of the first beam positioned on a first side of the precursor; a second lens system receptive of the second beam positioned on a second side of the precursor opposite of the first side.
15. The multi-photon excitation system as set forth in
16. The multi-photon excitation system as set forth in
a first lens system positioned at a first side of the precursor composition for focusing the beam of photons to a prescribed location in the precursor and collecting a fluorescence signal from the precursor composition; a frequency selective device receptive of the fluorescence signal from the first lens system; wherein the wavelength of the fluorescence signal is less than the wavelength of the beam of photons; and a first detector receptive the fluorescence signal from the frequency selective device for converting the fluorescence signal to an electrical signal provided to the controller.
17. The multi-photon excitation system as set forth in
18. The multi-photon excitation system as set forth in
a second lens system positioned at an opposing side of the precursor composition for collecting the fluorescence signal from the precursor composition; and a second detector receptive the fluorescence signal from the second lens system for converting the fluorescence signal to an electrical signal provided to the controller.
19. The multi-photon excitation system as set forth in
a waveguide receptive of the photon beam for guiding the photon beam therealong; and a probe receptive of the guided photon beam, the probe positioned in close proximity to the precursor composition.
20. The multi-photon excitation system as set forth in
an optical compensating device receptive of the photon beam for compensating for group velocity dispersion and self phase modulation; and a set of waveguide couplers for coupling the photon beam into and out of the waveguide.
21. The multi-photon excitation system as set forth in
22. The multi-photon excitation system as set forth in
23. The multi-photon excitation system as set forth in
24. The multi-photon excitation system as set forth in
25. The multi-photon excitation system as set forth in
a shutter controlled by the controller and receptive of the beam of photons for alternately passing and blocking the beam of photons; a beam splitter receptive of the beam of photons for splitting the beam of photons into a first beam and a second beam; a first lens system receptive of the first beam of photons and positioned at a first side of the precursor composition for focusing the first beam of photons to the precursor; a delay line for introducing a delay between the first and second beam of photons; a second lens system positioned at an opposite side of the precursor composition for focusing the second beam of photons to the precursor composition; wherein the first and second beam of photons are precisely aligned spatially and temporally at the precursor.
|
This application is a continuation of U.S. application Ser. No. 09/295,992, filed on Apr. 21, 1999, now U.S. Pat. No. 6,316,153, which claims benefit if U.S. provisional application Ser. No. 60/082,575, filed Apr. 21, 1998, which claims benefit of U.S. provisional application Ser. No. 60/112,797, filed Dec. 18, 1998.
1. Field of the Invention
This invention relates generally to methods of forming nanoscale structures and the nanoscale structures formed thereby. In particular, this invention relates to methods using multi-photon excitation for the fabrication of structures with nanometer-level precision.
2. Description of the Related Art
Three-dimensional objects having fine-scale microstructures possess unique and technologically attractive properties. There has been particular interest recently in the fabrication of structures with nanometer-level precision, that is, objects with structures or structural features measurable in the nanometer range. Such nanoscale structures have dimensions or features in the range of about 2 to about 100 nm (nanometer, wherein 1 nm=10 angstroms), which is on the order of the size of macromolecules such as proteins and protein complexes.
Photolithography, including methods using X-ray and deep UV, is well-known for producing two-dimensional structures with small-scale features. However, this technique does not allow the production of complex, curved three-dimensional surfaces, as it is very limited in the complexity achievable in the z-direction. Three-dimensional objects produced by photolithographic methods have therefore been essentially limited to columnar structures. Objects with features smaller than 150 nm are not readily producible or routinely available. George M. Whitesides has also described several methods for micro-scale fabrication based on microcontact printing and modification of surface chemistry with self-assembled monolayers. These methods, however, are also very limited in the ability to build in the third dimension, as well as in their chemistry. A method for manufacturing three-dimensional optical data storage and retrieval structures by reaction of polyesters using two-photon excitation is disclosed in U.S. Pat. No. 5,289,407 to Strickler, et al., which is incorporated herein by reference in its entirety.
A number of other, different approaches have been described for the synthesis of three-dimensional objects with small-scale features, for example biomimetic matrix topographies such as basement membrane textures. As described in U.S. Pat. No. 5,700,241, such structures are produced by removal of epithelial or endothelial cell layers to expose the supporting basement membrane or matrix. The exposed topography is then used as a mold for polymer casting. The surface of the resultant molded negative replica of the matrix topography is then itself cast with the final (bio)material of choice. With this methodology, three-dimensional biomimetic matrices can be prepared for both experimental investigations into cellular biology, and to potentially improve the cell and tissue response to implanted biomaterials. Although this method can produce very complex three-dimensional topography, it does not provide for topographic design flexibility, since all constructs must begin with a biological surface. In addition, while many materials may be used for fabrication, the procedure does not provide for spatial control of chemistry.
Scanning tunneling microscopy has also been used to move atoms on surfaces. However, this technique is extremely limited in the sizes and chemistry of the fabricated region. Another technique which has been described for the solid, free-form fabrication of microscale structures includes forming successive, adjacent, cross-sectional laminae of the object at the surface of a fluid medium or other bed, the successive laminae being automatically integrated as they are formed to define the desired three-dimensional object, as disclosed in U.S. Pat. No. 4,575,330 to Hull. U.S. Pat. No. 5,518,680 to Cima et al. similarly discloses successive printing of layers of powder in a solvent which causes binding of the successive layers, thereby allowing the formation of drug delivery devices having thicknesses on the order of about 100 microns.
Three-dimensional objects have also been generated by selective curing of a reactive fluid medium by a beam or beams of ultraviolet (UV) radiation brought to selective focus at prescribed intersection points within the three-dimensional volume of the fluid medium. Disadvantages of such systems include the use of UV radiation, which requires expensive and cumbersome optics and lens, as well as the associated poor focusing qualities of excimer and other UV laser sources.
An additional technique for generating three-dimensional microscale objects is described by S. Maruo, O. Nakamura, and S. Kawata et al. in "Three Dimensional Microfabrication With Two-Photon-Absorbed Photopolymerization", Optics Letters, Vol. 22, No. 2, pp. 132-134 (1997), which is incorporated herein by reference in its entirety. Maruo et al. discloses that microscale structures are formed by subjecting urethane acrylate monomers and oligomers to near-infrared laser light in a non-solvent system. Use of two-photon absorption for initiation of the reaction leads to a spiral wire having a diameter of 6 microns, an axial pitch of 10.3 micron, and a width of nearly 1.3 microns. While small, such structures are not in the nanoscale region. Maruo et al. furthermore only describe synthesis in a non-solvent system, which is incompatible with most biomolecules.
Accordingly, there still remains a need for methods of free-form fabrication of two- and three-dimensional structures having dimensions or features in the micron and nanometer range, especially techniques suitable for synthesis using biomolecular subunits such as proteins, peptides, oligonucleotides, as well as bio-active small molecules such as hormones, cytokines and drugs.
The above-discussed and other drawbacks and deficiencies of the prior art are overcome or alleviated by the method and apparatus of the present invention, wherein small, two- or three-dimensional structures are formed by multiple-photon-absorbed photopolymerization and/or cross-linking of a precursor composition, that is, photopolymerization using multi-photon excitation. Use of multi-photon excitation allows fabrication of structures and structural features having at least one dimension of less than about one micron, preferably less than about 500 nm, more preferably less than about 250 nm, and most preferably of less than about 100 nm, in bulk phase as well as in solution, and from a wide variety of organic and inorganic precursor subunits, including synthetic polymers and biological polymers such as proteins, lipids, oligonucleotides, and the like.
In one embodiment, use of two-photon far field optics allows the formation of structures having X-Y dimensions of less than about 300 nm and a Z dimension of less than about 500 nm, while use of three-photon far field optics allows the formation of structures having X-Y dimensions of less than about 250 nm and a Z dimension of less than about 300 nm. In a particularly preferred embodiment, use of a 4 pi optical configuration in combination with two-photon far field excitation allows the formation of structures having X-Y dimensions of less than about 150 nm and a Z dimension of less than about 100 nm. In another embodiment, use of multi-photon near field optics results in the formation of structures having X, Y, and Z dimensions of less than about 50 nm. In this embodiment, near field fabrication is achieved by two-photon excitation through fiber probes. In a related embodiment, the optical element of the near field embodiment is coupled with a multiple barreled pipette for precise delivery of components into multiple areas simultaneously or sequentially.
The method described herein is useful for the formation of a variety of small-scale structures. In one embodiment, noncross-linked agents are entrapped (permanently or temporarily) in a gel or matrix formed by multi-photon excitation. Such gels or matrices may have controlled release, degradation, and/or diffusivity properties. Agents include proteins, peptides, carbohydrates, drugs, enzymes, liposomes, nucleotides, and cells. In a related embodiment, multi-photon excitation is used to fabricate devices having varying cross-link densities and/or chemistries to produce materials having variable degradation properties for use as controlled release devices in drug delivery, biomaterials, tissue engineering, and environmental applications.
In another embodiment, multi-photon excitation is used to modify the surface of biological or conventionally fabricated materials. The materials may have complex surface features, or the present method may be used to provide complex features to the materials. Exemplary applications include adding one or more bioactive functions to an integrated circuit (IC) chip, manufacturing biomimetic surfaces for use with tissue cell culture, and modifying explanted tissue for re-implantation or other uses. The combination of microscopy and multi-photon excitation allows the micro-positioning of one or more features on a surface. In a related embodiment, multi-photon excitation is used to manufacture ciliated surfaces or other micro-sized transport devices using motile proteins.
In another embodiment, multi-photon excitation is used to create structures which, in conjunction with shrinkage or expansion effects, dynamic shape change effects (i.e., Poisson ratio effects), and/or groups active under certain chemical conditions, will result in more complex structures. Such structures may be used as a variable filter or as a small-scale actuator to exert physical force, alter fluid flow, and the like. In a related embodiment, optical devices are manufactured in layers and/or in other two- and three-dimensional configurations by configuring optically active and chiral compounds.
In another embodiment, multi-photon excitation is used to provide spatial orientation of enzymes on or within substrates or manufactured constructs. Organization is provided by application of electrostatic fields, selective adsorption, shear forces and by optical and magnetic traps.
In another embodiment, proteins are cross-linked directly, without use of photosensitizers or chemical crosslinking agents.
In another embodiment, multi-photon excitation is used to effect nanofabrication at remote sites via optical fibers. Such optical fibers may be placed, for example inside a catheter. Nanofabrication in this embodiment includes delivery of drugs or other biologically active agents, controlled delivery of tissue engineering scaffolding agents, growth factors, and the like; and minimally invasive assembly of structural elements or devices such as stents.
The method and apparatus of the present invention allows the formation of structures having smaller dimensions than before possible. The above-discussed and other features and advantages of the present invention will be appreciated and understood by those skilled in the art from the following detailed description and drawings.
Referring now to the drawings wherein like elements are numbered alike in the several FIGURES:
In accordance with the present invention, small two- or three-dimensional structures are formed by multiple photon induced polymerization or cross-linking of a precursor composition. For convenience, "structures" and "constructs" as used herein refers both to microscale and nanoscale objects in their entirety, that is, objects having overall X-Y or X-YZ dimensions in the micron and nanometer range, as well as larger objects having features with X-Y or X-Y-Z dimensions in the micron and millimeter range. "Multiple photon excitation" as used herein means the simultaneous absorption of multiple photons by a reactive molecule. The method is particularly suitable for the formation of three-dimensional objects or structures having dimensions on the micro- and nanometer scale, that is, structures built up from elements with point volumes having dimensions of less than about 1 micron, preferably elements having at least one dimension of less than about 500 nm, 250 nm, 100 nm, and most preferably less than about 50 nm. The structure geometry will depend on the optical method used for photo-excitation and reaction of the precursors, the movement of the laser and/or stage, and the choice of precursors, as dictated by the desired morphology of the final structure. While the following discussion is directed to laser excitation, it is to be understood that other methods for achieving sufficient photon density are also within the scope of the present invention.
As shown schematically in
The squared or cubed point-spread function associated with two- or three-photon laser absorption, respectively, results in only a small volume of the reactive species being exposed to the applied radiative energy. Where the photon density is high, molecules at the focal point capable of absorbing a UV or short wave photon absorbs two (or three) near-IR photons at the same time, thereby forming at least one reactive species such as a radical or radical ion. This reactive species then reacts, or propagates via radical- or cation-based chain reactions, until chain termination steps are reached, forming polymerized or cross-linked areas thereby.
Two- or three-dimensional objects 18 are formed by successive movement of the photon beam and/or stage 16 until the desired structure is built point by point. For example, light may be directed onto an X-Y plane by sequential movement of the laser. The stage is then be moved in the Z-direction an appropriate amount, and second, third, and higher X-Y lamellar structures are formed. This method of three-dimensional structure formation is similar to the successive layer formation as described by Cima et al., but allows the formation of structures having smaller features in all three planes. This method is furthermore not limited to this formation sequence, in that any combination of laser/stage movement may be used. Thus, the method of Maruo et al., which discloses only movement of the stage, is limited to formation of structures of greater than 1 micron, possibly because of optics and other conditions, but also possibly because movement of a stage is slower. The fastest volume formation based on stage movement as described by Maruo et al. is approximately 1 pixel per 1, or even 10, milliseconds. Laser movement, on the other hand, is faster, on the order of the formation of 1 pixel per microsecond. Structures of high three-dimensional complexity are thus available, in a shorter period of time.
A number of advantages result from the use of multi-photon excitation in accordance with the present method, notably the ability to probe deeply into a bulk or solution phase sample with an unprecedented degree of control in the x- and y-, as well as z-directions, with only minimal optical effects above and below the focal point. Thus use of multi-photon excitation allows synthesis with various biomolecules, in that infrared, red, deep red, and visible light illumination minimizes damage to proteins, enzymes, or organic molecules adjacent to the focal point, due to the minimal absorbance and scattering of IR and red light compared to UV light. Use of IR and red light also permits fabrication within tissues and through turbid media such as blood. A further advantage is that it is possible to limit the size of a fabricated feature to an area even smaller than the focal point of the photon source, by focusing the activation zone (the area of high proton density) partially within a non-reactive substrate or other location where activation does not occur.
Other advantages are that the deep red, red, infrared, and other visible light optics are less expensive and cumbersome than those required and available for activation using UV radiation. Lasers operated at these wavelengths also provide diffraction limited light sources, unlike conventional UV excimer lasers. A wider range of activation molecules are available (deeper UV) without damage or unwanted side reactions than is possible using UV activation. Fiber optics may be easily used for light transmission, resulting in higher energy, less beam spread, better collimation, and less chromatic spread compared to using UV-associated optics.
Nonlinear optics are presently preferred in the practice of the present invention. There are a number of advantages to use of nonlinear optics in freeform fabrication, one of the most important being that it allows for high energy peak power to be confined to a smaller area than that achievable with linear infrared optics. Practical realization of two-photon laser scanning microscopy is described by W. Denk, J. H. Strickler, and W. W. Webb in Science, Vol. 248, p. 73 (1990), which is incorporated herein by reference. Other uses and descriptions of two-photon excitation are further described by O. Nakamura in Optik, Vol. 93, p. 39 et seq. (1993); by O. Nakamura and T. Okada in Optik, Vol. 100, p. 167 et seq. (1995); by E. S. Wu, J. H. Strickler, W. R. Harrell, and W. W. Webb in Proc. SPIE, Vol. 1398, p. 107 et seq. (1990) and in U.S. Pat. No. 5,289,407 to Strickler and Webb; and by Watanabe, M. Okawa, T. Ukachi, F. Kurihara, and H. Harimaya, In Proceedings of RadTech Asia 1993, p. 462, published by RadTech, Japan (1993), the relevant portions of which preceding references are also incorporated by reference herein. "A Light Source Smaller Than the Optical Wavelength" by K. Liebermann, S. Harush, A. Lewis, and R. Kopelman, Science, Vol. 247, pp. 61 (1990) is further incorporated by reference herein.
In preferred embodiments, use of two-photon wide field (far field) excitation allows the formation of structures comprising individual point volumes with X-Y dimensions of less than about 300 nm and optionally a Z dimension of less than about 500 nm, while use of three-photon far field excitation allows the formation of structures comprising individual point volumes with X-Y dimensions of less than about 250 nm and optionally a Z dimension of less than about 300 nm. A schematic diagram of an apparatus 20 suitable for use with two-photon or three-photon far field (nonlinear) optics is shown in
In another preferred embodiment, use of a 4 pi far field optical configuration in combination with two-photon excitation allows the formation of structures comprising individual point volumes having X-Y dimensions of less than about 250 nm and a Z dimension of less than about 100 nm. 4 Pi optics in connection with fluorescence microscopes is described by S. Hell and E. H. K. Stelzer in "Fundamental Improvement of Resolution With a 4 Pi-Confocal Fluorescence Microscope Using Two-Photon Excitation", Optics Communications, Vol. 93, pp. 277-282 (1992), which is incorporated herein by reference in its entirety. The apparatus of
4 Pi optics require objective elements both above and below the sample. The fabrication of tall or thick objects is thus limited by the working distance of the objective elements, at this point to about 200 microns at the highest resolutions. In addition, any supporting material and the item to be fabricated must be transparent at the appropriate visible, red or infrared wavelengths. However, this method also provides the ability to make very small features with excellent spatial precision very quickly, due to high photon densities at the mutual focal point of the two objective lens elements. This embodiment is thus particularly useful for the production of thin objects with complex features, such as masks for photolithography, coatings, membranes, and sensors.
In another embodiment, use of multi-photon near field optics results in the formation of structures comprising point volumes having X, Y, and Z dimensions of less than about 50 nm. The apparatus 40 of
In another embodiment, the optical element of the near-field embodiment is coupled with a multiple-barrel pipette (shown in shadow in
A variety of precursor materials are suitable for use in the present method, as long as such compositions do not substantially absorb the radiation used for polymerization or crosslinking adjacent to the focal point. Substantial transparency allows more precise focus of the laser beam, and minimization of unwanted side reactions. Use of visible, near infrared, infrared, or deep red illumination also minimizes damage to precursors adjacent to the focal point since most organic/inorganics, polymers, proteins, nucleic acids, and lipids have minimal absorbance and scattering cross-sections at red and near-IR wavelengths. Reaction of the precursor solution in accordance with the present invention may occur in bulk (in either liquid or solid phase), in solution, adsorbed to a substrate, or in suspension or emulsion. Any solvent must also be substantially transparent to the radiation used to fabricate the structures.
One type of suitable precursor compositions are polymerizable or crosslinkable (usually by free radical or cationic mechanisms) upon photoinitiation. Photoinitiable polymerizable or crosslinkable precursor compositions will therefore ordinarily comprise an initiator for initiation of the reaction, as well as monomers, oligomers and/or polymers and/or crosslinkers capable of free radical or cationic chain propagation and chain termination steps. The initiator may or may not be covalently attached to the crosslinker, monomer, oligomer, and/or polymer.
Suitable photoinitiators for radical polymerization include, but are not limited to azo compounds such as azobisisobutyronitrile, peroxides such as benzoyl peroxide, aliphatic carbonyl compounds such as ketones and diketones, and aromatic diketones such as benzophenone and its derivatives, and 9-fluorenone 2-carboxylic acid. Other photoinitiation systems include, but are not limited to, redox-type photoinitiators useful in aqueous systems (e.g., ion pairs such as Fe3+OH-, and Pb2+Cl-), photosensitive dyes such as eosin, rose Bengal, and erythrosin, and transition metal derivatives such as Mn2(CO)10 in the presence of organic halides.
Suitable free radical polymerizable compounds include, but are not limited to crosslinkers, monomers, oligomers and/or polymers having at least one olefinic (unsaturated) bond, such as crosslinkers, monomers, oligomers and/or polymers which form polyalkylenes and halogenated polyalkylenes, polyacrylates, polymethacrylates, polyacrylamides, and styrenes.
Photoinitiators for cationic polymerization include but are not limited to triarylsulfonium and diaryliodonium salts with complex metal halide anions, and mixed arene cyclopentadienyl metal salts of complex metal halide anions, such as (6-benzene)(5-cyclopentadienyl)Fe(II) hexafluorophosphate. Suitable cationic polymerizable compounds include but are not limited to epoxides such as cyclohexene oxide.
Photopolymerizable precursor compositions are also suitable for use with the present invention. In photopolymerizable compositions each propagation step is effected by the incident radiation, and photopolymerization may be achieved using photo-crosslinking agents such as bisarylazides or photocross-linkable oligomers and polymers. Such oligomers and polymers contain chromophoric groups that undergo light-induced chemical bonding with each other. The chromophoric groups may be in the polymer backbone, for example a backbone chalcone group, or pendent, for example a poly(vinyl cinnamate).
The above descriptions of suitable precursors are categorized by reaction mechanism for the purposes of convenience only. It is to be recognized that other polymerizable or crosslinkable precursors, alone or in combination with other photoinitiators, are also within the scope of the present invention, wherein the precise mechanism of polymerization (e.g., radical polymerization, single electron polymerization, or photopolymerization) is not clearly known. Thus, essentially any precursor composition which is photo-activated to form crosslinks with the fabricated construct with or without an intermediary cross-linker, and which is substantially transparent to the radiation outside the focal point is within the scope of the present invention. Such precursors include, but are not limited to, the above-described and other organic monomers (including dyes and chiral species), oligomers, and polymers, including biopolymers.
Biological monomers and polymers are of particular interest, including but not being limited to amino acids, peptides and proteins; fatty acids and lipids; nucleotide, oligonucleotides, and their synthetic analogues; nucleic acids; sugars and carbohydrates; bioactive agents such as cytokines, hormones, receptors, growth factors, and drugs; optically active synthetic agents (including inorganic compounds); and optically active bio-compounds such as caged compounds and fluorophores. These molecules are not readily amenable to nanofabrication, as they are often only sensitive to UV light, and must be reacted in solution, problems which are solved by the present method.
As described in the Examples below, a number of organic polymers in various configurations have been fabricated. Polyurethane structures have been assembled and crosslinked using an optical adhesive preparation commercially available from Norland under the trade name Optical Adhesive #83H (
Trimethylolpropane triacrylate has been polymerized in combination with Rose Bengal (two-photon excitation) or 9-fluorenone-2-carboxylic acid (three-photon excitation).
Polymerization of acrylamide using two-photon excitation in the presence of several other activators has been used to fabricate three-dimensional structures as in
Fabrication has also been demonstrated with biologically active molecules. Bovine serum albumin (BSA, a soluble globular plasma protein) in an aqueous solution has been polymerized into a synthetic construct in the presence of Rose Bengal (
A number of factors affect the ultimate dimensions and degree of polymerization or crosslinking of the formed construct, and thus the ultimate properties and dimensions of the final structure. Such factors are often interrelated, and include, for example, the size of the focal point, the identity of the precursors, the mechanism of crosslinking or polymer formation, the substitution patterns of the reactive groups, the stability of intermediates, diffusion of intermediates or precursors, the competing reactions, the presence of reaction accelerators or inhibitors, and the like. For example, without being bound by theory, it is hypothesized that smaller structural dimensions are obtainable by the method of the present invention when less stable reactive intermediates are generated, or when the number of chain propagation reactions is limited. Larger structures may be synthesized using more stable intermediates, thereby allowing one or a combination of radical species to diffuse away from the focal point of the laser, or for chain polymerization to occur beyond the focal point of the laser, and terminating only upon the occurrence of chain terminating steps. Smaller species may also diffuse beyond the focal point of the laser, ultimately leading to larger structures. Focus of photon density partly within an inactive substrate of other inactive locale will result in a smaller construct.
In case of the polyurethane and albumin, however, free radical (or single electron) polymerization or cross-linking may occur, but only to a limited extent because of the instability of the formed free radicals or the favored energetics of chain termination steps. Alternatively, photopolymerization alone may occur, which by its nature is limited to the focal point of the laser. In any event, the size of the formed structure depends not only on the size of the laser focal point, but also on the nature of the precursor composition, wherein less-stable radicals or other intermediates result in structures having smaller dimensions.
A significant advantage of the method of the present invention is that it allows fabrication of micro- and nanosized structures having almost unlimited geometries. As mentioned above, two- or three-dimensional objects are formed by successive movement of the laser beam and/or the stage containing the reactive species until the desired structure is built point by point. The morphology of the final structure will thus depend at least in part on positional control of the beam or the stage used for polymerization.
Objects comprising multiple materials may also be fabricated, by changing the precursors sequentially. Alternatively, precursors with different wavelength sensitivity may be used in conjunction with a variable wavelength laser or multiple lasers. Changing the wavelength allows selective fabrication of two or more components at the same time (this process is illustrated schematically in FIG. 1). The fabrication method of the present invention may also be used in conjunction with other fabrication methods, such as physical trapping of a compound within an optically nanofabricated cage, gel, or matrix.
In one embodiment, multi-photon free-form fabrication is used to place active (preferably bioactive) agents into three-dimensional photo-crosslinked and/or photopolymerized gels or constructs which have controlled release, controlled degradation, and/or controlled diffusivity properties. Bioactive agents which may be so placed include, but are not limited to growth factors, nucleotides (DNA, RNA, antisense), ions, buffering agents, dyes, proteins, peptides, carbohydrates, glycosaminoglycans, enzymes, nucleotides, liposomes, cells, and drugs. Diffusion of the agent or agents out of the construct is adjusted to effect controlled release, or to expose or otherwise bring the entrapped agent or agents to the construct surface or other interface to enable bioactivity. Diffusion is controlled by one or a combination of methods, for example by control of the affinity of the agent or agents for the construct, control of the degree of crosslink density of the construct, or control of the rate of degradation of the construct. Control of the degree of affinity of the agent or agents for the construct may be achieved by appropriate selection of the construct composition, e.g, backbone and/or crosslink compositions. Use of differing cross-linking moieties allows adjustment of relative affinities of two or more agents. Entrapment of agents having different construct affinities allows controlled release at different rates.
Control of diffusion and degradation properties is most readily achieved in a chemically uniform gel by locally varying the cross-link or polymerization density. This may be achieved by varying illumination time, intensity (photon energy density), and/or by altering gel architecture, including variation of the gel's spatial dimensions, addition of overlayers of gels without entrapped reagents, and other three-dimensional patterning. Control of diffusion and degradation can also be achieved by varying gel chemistry, such as by varying cross-link chemistry, using different monomers, and by altering the rate of polymerization or cross-linking by changing other reactant constituents.
In another embodiment, multi-photon free-form fabrication is used to place active (preferably bioactive) agents into three-dimensional photo-crosslinked and/or photopolymerized gels or constructs more permanently. Alkaline phosphatase has been entrapped in polyacrylamide gels as described in Example 7. Higher density gels inhibit diffusion of a reagent into gel from the edges. Enzyme activity is also decreased in regions where the construct is in closer contact with the substrate. It is theorized that diffusion of reagent is inhibited in these regions.
In one form of this embodiment, such entrapped agents include entrapped enzymes that continuously act on molecules which diffuse into the gel or construct before the molecules diffuse out of the gel or construct. In another form, such entrapped agents include entrapped enzymes, chelators, or other molecules which act on molecules which diffuse into the gel, and through this action become unable to leave the gel or construct. Entrapped agents provide a filtration or trapping function, which may be useful in biosensor and other detection applications. In another form of the present embodiment, such entrapped agents include entrapped motile proteins, peptides, or non-biochemical structures which cause the fabricated construct to wiggle, change shape, or change its diffusion properties when specific molecules, ions, or others agents diffuse into the gel. In another form of the present embodiment, such entrapped agents include entrapped photodynamic molecules which change color, refraction, diffusion, transport, shape, or other physical properties or biochemical activities when illuminated at certain wavelengths, polarizations, or other states of light. In another form of the present embodiment, such entrapped agents include entrapped chemoactive molecules which change color, refraction, diffusion, transport or other physical and/or biochemical properties due to the activity of chemical agents which diffuse into a gel or other construct such as ions, pH, and biomolecules.
Manufacture of gels comprising entrapped proteins is particularly useful for fabrication of detection and separation systems which function on nanometers to micron scales. An example of this type of fabricated gel includes entrapment of proteins selected from the group consisting of nano-Ochterlony-like immunodiffusion assays (for antigen-antibody precipitation), nanoscale polyacrylamide electrophoresis (PAGE) gels, PAGE gels with optically fabricated nanoscale gradient densities, and nanoscale separations and detection systems such as Southern blot, Western blot, Northern blot, and polymerase chain reaction (PCR) wells.
Entrapment (or encapsulation) of living cells in particular has application in tissue engineering, cell culture, cell bioreactors and in detection (biosensor) systems. Such entrapment may be temporary or permanent. It is known that multi-photon microscopy generally has minimal effect on cell viability, due to the long wavelengths used and the highly spatially restricted excitation zone. The optical aspect of fabrication is thus unlikely to provide any major impediments to cell entrapment.
Entrapment includes both physical entrapment of cells within a construct, such as a gel or a scaffold, chemical cross-linking of the cell surface to a construct, or crosslinking of one cell to another. Encapsulation of cells is by polymerization of the construct around the cell. Where necessary, the potential for any photodamage is minimized by building a "box" around a cell without directly contacting the cell so entrapped. Since the optical zone for fabrication is limited to a few hundred nanometers, which is much smaller than a cell, photo-excitation may be limited to specific cell regions. The present method thus also includes directly cross-linking or "tethering" cells to constructs by directly linking the construct to, e.g., cell-surface glycoproteins. This effectively provides a means to establish cell positioning on a scaffold. Preferred cells for this application is cells having robust cell walls, such as bacteria and plant cells. Multi-photon excitation may also be used to provide cross-linking within and between cells which have been entrapped.
In another embodiment, multi-photon excitation is used to modify the surface of materials which have complex textures, chemistries, or biochemistries, or to provide complex textures, chemistries, or biochemistries to surfaces. Exemplary surface modification includes the attachment of active agents directly to cell surfaces by multi-photon mediated cross-linking. This would facilitate delivery of agents directly to specific cells, complemented by pinocytotic processes, which cause these agents to be taken into the cell. Another example is addition of one or more bioactive functions or detection elements to a substrate such as in integrated circuit or other device. The fine positioning of such functions or elements using the microscope portion of the apparatus represents an important advantage of the present technology. An example of such surface modification is the fabrication of fibrinogen scaffolds for the adhesion of blood platelets.
An especially useful application employing surface modification is the manufacture of biomimetic surfaces for use with tissue cell culture, especially the provision of surfaces which replicate biological textures such as subendothelial and subepithelial extracellular matrices and basement membranes, and other tissue topographies. U.S. Pat. Nos. 5,380,589 and 5,700,241 are relevant in this regard. The surfaces of bone implants maybe modified as described in U.S. Pat. No. 5,370,692 to Fink et al., which is incorporated by reference herein.
Another example of surface modification using multi-photon excitation is the manufacture of micromachines using motile proteins, for example by affixing kinesin, microtubules, actin, axonemes, flagella, or other motile structures to fabricated constructs in a spatially organized manner. This is used to manufacture ciliated surfaces or devices to transport molecules along a desired path or to make devices which move using biochemically driven mechanisms.
In another embodiment, multi-photon fabrication is used to manufacture biosensors, environmental sensors, and chemical sensors. A schematic diagram of a biosensor array chip using, for example, antibodies or oligonucleotide is shown in FIG. 16. Current technology can achieve about 1.5×103 assay sites per square centimeter. The nanofabrication technology of the present invention could conservatively achieve a density of 1.6×109 assay sites/cm2 in two dimensions using multi-photon excitation, or conservatively up to 6.4×1011 assay sites/cm2 in three dimensions using multi-photon excitation. U.S. Pat. No. 5,556,752 to Lockhart et al., which is incorporated by reference herein, discloses an array of double-stranded oligonucleotides on a solid support useful for screening.
In another embodiment, the present method is used to provide spatial orientation of enzymes, antibodies, receptors, ribosomes and the like relative to substrates or within manufactured constructs in order to produce useful biochemical or chemical work from such assemblies. These "biochemical factories" may be biomimetic in overall organization or artificial, in the sense that novel structures are produced. Such factories include arrays of enzymes to effect electron transfer, to perform biochemical synthesis, to perform separations, and to cause biomolecules in solution to interact with those in the fabricated device with specific orientations.
Fabrication with the appropriate spatial and biochemical organization allows several enzymes to act, in turn, on added reactants for synthetic, degradative, transport, transduction, and/or other functions. To effect proper orientation of enzymes and the like during fabrication, external forces may be applied such as electrostatic an/or magnetic fields, shear forces, laser tweezers, and magnetic tweezers. Proper orientation may also be facilitated by permitting self-assembly by using other molecules as chaperones, and by using flexible tethers to connect enzymes and the like to substrates. Another method is to bind soluble macromolecules to link structures together in solution, and then to link the entire unit to the device to be fabricated where desired, followed by macromolecular ligand release. Macromolecular ligand release may be mediated by altering ionic strength, use of soluble enzymes, or other processes, thereby leaving the desired molecule on the surface in the proper orientation to bind ligands.
In another embodiment, multi-photon excitation is used to modify explanted tissue prior to re-implantation. In in vitro tissue modification, the tissue is first removed, through for example, a homograft, allograft or xenograft. The properties of the removed tissue are then modified by effecting crosslinking by multi-photon excitation with suitable crosslinking agents, and/or by diffusing in agents to incorporate specific activities or to effect other processing. The tissue is then implanted or otherwise used. A specific example of this methodology is the improvement of physical properties and decrease in potential infection and calcification of tissue-based xenogeneic heart valves. Increases in strength, alterations in flexibility, or improvement of other properties such as decreasing or eliminating the need for aldehyde and other chemical cross-linking fixations is achieved by selectively incorporating crosslinks into identified regions using multi-photon excitation. Incorporation of agents (e.g., chelating agents or antibacterial agents) into the xenogeneic tissue by crosslinking will result in decreased calcification and susceptibility to infection, respectively.
In another embodiment, multi-photon excitation is used to fabricate molds, stampers, masks, or other forms for multiple production. In particular, masks for photolithography having smaller dimensions than those presently in commercial use are available by the present method. Currently, high-resolution masks for research purposes with features in the range of about 150 nm are very expensive. The present technology allows fast, efficient production of such masks with comparably-sized or smaller features, and with multiple precursor types. Another application of this type is surface molds for biomimetic extracellular matrix textured surfaces for tissue culture, tissue engineering, and biomaterials.
In another embodiment, dynamic shape change in formed objects is achieved by using Poisson ratio effects, controlled shrinkage/expansion effects, and/or by incorporating chemical groups, proteins and other elements into the precursor compositions which, upon polymerization or crosslinking will swell or otherwise change shape. Such elements optionally include a "smart" polymer or a biopolymer, such as an enzyme or motile protein, which will change its shape (for example, bend, elongate, shrink, move, or coil) with a change in media condition (for example, temperature, solvent, ionic strength, or addition of specific ligand). Such materials may be used as actuators, i.e., to dynamically change shape to exert physical force, alter fluid flow, or change other properties. As examples of the present method, biosynthetic mechanical structures may be produced by placing tubulin monomers at ends of a nanofabricated rod to make a dynamic cytoskeletal-like element; a kinetochore may be incorporated to form microtubules; or profilin may be incorporated to form actin. Additionally, change in the shape of a structure may be used to open or close pores (i.e., act as a variable filter), or to expose an active functionality such a one or more antibodies or cell surface receptor ligands. Such structures would as a second functional element to "trap" antigens or specific cells.
In another embodiment, multi-photon excitation is used for direct protein crosslinking without the addition of photosensitzers or chemical crosslinkers, as illustrated in FIG. 19. The π to π* transition (266 nm) of proteins or peptides containing aromatic residues is excited by simultaneous absorption of three 800 nm photon of 100 femtosecond pulse width. Following this excitation a second time delayed beam excites the chromophore above the ionization limit. This is done by a two photon process with 800 nm or by one photon of 400 nm. Transiently, the chromophore forms a zwitterion which covalently binds to a second protein or peptide. The power dependence of the multi-photon absorption process leads to three-dimensional confinement of activation on the microscopic scale. Such confinement is defined by the initial three photon process and the second step may therefore proceed equivalently with one or two photon excitation.
The method of the present invention is further used to manufacture optical devices in layers and in other two and three-dimensional configurations, using chiral and optically-active compounds having specific organizations. By virtue of assembly of elements smaller than most visible optical wavelengths, such assemblies are effective to alter diffraction, refraction, become optical waveguides, and otherwise manipulate optical properties.
In another embodiment, at least one fiber optic element is used to effect nanofabrication by multi-photon excitation in locations which are otherwise inaccessible, preferably by using a fabrication apparatus in combination with a catheter. As shown schematically in
Several mechanisms may be used to effect the placement of the lens at the focal distance from the point where fabrication is desired. A cowling 70 may be used to provide this spacing. Alternatively, spacing may be obtained by incorporating imaging capability through the catheter and providing opto-mechanical means to move the assembly, to adjust the focal length, and/or to scan a beam. Reagents for assembly and fabrication may be introduced via reagent tubes 68 tubes within the catheter. With several such reagent tubes, multiple compounds may be delivered to permit fabrication of multi-component constructs, and to provide different functionalities in different locations. In addition to fabrication, multi-photon processes can also be used for ablation, such as may be desired to clean surfaces, or as a preparative procedure prior to applying other reagents. Such catheter or fiber optic systems are of use in minimally invasive vascular and other surgical procedures, dentistry, and other applications such as for repair of pipes and conduits within man-made structures and instruments.
Two methods may be used for producing beam scanning with a single mode optical fiber inside a catheter. The first is use of a mirror 70 (scanning galvometer), much as is done with the non fiber-based apparatus. The second (FIG. 20C)is simpler, wherein the fiber is moved in the back focal plane of the objective lens. Single mode fibers have openings of 3 microns and coupling efficiency is approximately 50%. As described above for near-field fiber-optic probes, a post laser prism or grating pair is used to compensate for the GVD and SPM in the fiber.
Since this apparatus is basically a fiber optic microscope, this feature is exploited to image a region prior to instituting fabrication. For example, the device is used as a scanning microscope to image damaged tissue (e.g, a wound, chronic sore, corneal defect or torn articular cartilage) in situ with minimally invasive methods. Imaging may be obtained in reflective mode, as may be appropriate for teeth and other hard tissues with high reflectance, or by using multi-photon fluorescent imaging with low reflectance soft tissues. Rose Bengal, eosin, and erythrosin are exemplary nonspecific fluorescent labels, since they are diffusible, non-toxic, and also suitable photo-initiators for fabrication. Other agents and intrinsic fluorescence may also be used.
In situ tissue repair comprises imaging a lesion in damaged tissue in three dimensions using the fiber optic device system as a scanning microscope, wherein imaging is in reflective mode (confocal) and/or in fluorescent mode using two-photon imaging, creating a three-dimensional digital map of the damage using the confocal/multi-photon image(s) to calculating a plan for repair, placing repair subunits using a direct scan system, and optionally cross-linking the edges of the repair material to the surrounding tissue to hold it tightly in place.
The multi-photon fabrication methodology, in both the in vitro and the in situ system, may be used to fabricate at some depth into tissue. Since most soft tissues exhibit considerable transmission in the near IR, tissue modification may be made to about 350 microns deep into soft tissue, such as skin and gingiva. Materials for fabrication (with low toxicity) are then diffused into tissues in the form of low molecular weight precursors. Factors for affecting effective fabrication depths are diffusion of the materials for fabrication, Rayleigh scattering of light which scales as the quartic power of the frequency, and photon density at long working distances, which is a function of laser power and numerical aperture. Hence it is advantageous to use near infrared light to achieve significant depth.
The ability to fabricate in situ and below surfaces may be broadly applied in medicine and dentistry. Some examples include: a) delivering antisense, anti-angiogenesis compounds, cytotoxins directly into or onto tumors, where agents are optionally delivered in controlled release formulation or configuration; b) using the apparatus for controlled delivery of tissue engineering scaffold agents, growth factors, and cells to i) facilitate wound healing in chronic sores, ii) provide a matrix for chrondorcytes growth in damaged articular cartilage, or iii) repair of arterial walls following angioplasty or other trauma; c) fabrication of matrices with the fiber optic device placed against the gingiva in order to effect photo-optical fabrication directly in the sulcus space, to deliver and attach antibacterial agents, growth factors and other agents to diseased tissue in a minimally invasive approach, or to deliver therapeutic agents to diseased and damaged gingival and other epithelial lesions, to kill tumors, and to promote healing of chronic wounds, d) in situ photodynamic therapy, as disclosed, for example, by J. Bhawalkar and N. Kumar et al. in "Two-Photon Photodynamic Therapy," Journal of Clinical Laser Medicine & Surgery, Vol. 15, pp. 201-204(1997); e) in situ fabrication of matrixes for, for example, the guided regeneration of articular cartilage and/or simultaneous entrapment of chondrocytes into the regeneration matrix, f) fabrication of scaffolds for epithelial wound repair in skin, cornea and other tissues at, or below the surface, g) assembly of minimally invasive scaffolds in situ to restore, effect repairs, or strengthen tendon and ligament attachment, h) site directed repair and rebuilding of anuretic or hemorrhagic arteries via minimally invasive reconstruction for cardiovascular medicine, i) delivery of controlled release pharmaceutics and bioactive agents to plagues, tumors, lesions, and chronic wounds; and j) minimally invasive assembly of structural elements or devices such as stents.
Configuration for fiber coupling into a fiber optic is straightforward for continuous wave or nanosecond pulsed lasers, but is much more complex for femtosecond lasers. Both group velocity dispersion (GVD) and self-phase modulation (SPM) must be considered in coupling short laser pulses. GVD occurs when light travels through a dispersive medium such as a silica fiber. For monochromatic light, this issue is negligible. However, a 100 femtosecond laser pulse has a spectral width of about 10 nm full width half maximum (FWHM), and its components typically have different refractive indices in a fiber, resulting in a positive frequency "chirp" where the red components travel faster than the blue components. After propagating though a long fiber, the pulse is broadened out to a few picoseconds. SPM results when a spectrally broad pulse of high peak power is focused tightly, as into a 10 micron single mode polarization preserving fiber. The peak power modulates the refractive index and adds frequency components to the red and blue, and the 10 nm spectral width considerably broadens. The solution is to pre-chirp the pulse with a grating pair, which provide negative dispersion, reducing the peak power and thereby minimizing SPM. The positive dispersion of the fiber probe will then recompress the pulse to near 100 femtoseconds. Both second and third order dispersion can be compensated through this process with the proper choice of optics and was recently demonstrated by Lewis et al. Since a microscope is an integral part of the apparatus for practice of this embodiment, precise placement of a multi-photon-fabricated feature or device on a surface or in tissues is readily achievable.
The above-described embodiments may also be combined as desired in order to create complex devices and structures. For example, devices with a combination of enzymes, motile proteins and optical properties may be used for biosensor applications. Fiber optic fabrication systems may be used for catheter-driven repair of tissue damage. or to deliver biodegradable compounds to effect tumor killing.
The invention is further illustrated by the following non-limiting Examples.
Apparatus
The apparatus used in the following Examples is shown schematically in FIG. 21. It comprises a modified BioRad laser scanning confocal microscope (BioRad MRC 600) having a computer 26, galvoscanner 27, and a 0.5-1.4 objective lens 22 for focus on stage 16. Fabrication is monitored using florescence detection via photomultiplier tube 82 and/or the condenser lens 84 and photomultiplier tube 86. The microscope is fitted with a femtosecond titanium:sapphire laser 80 (Coherent Mira 900-F).
A polyurethane-based optical adhesive precursor system was obtained from Norland Products Inc., N. Brunswick, N.J. having the trade name Norland Optical Adhesive 83H. This adhesive system is ordinarily activated by exposing the adhesive precursor to UV light at 320-380 nm with peak intensity at 365 nm. Adhesive precursor was placed on a microscope slide on a stage which could be manually scanned in the X-Y plane. A focused beam was scanned on the precursor at a wavelength of 790 or 785 nm and pulse lengths of 100 femtoseconds and average power of 10 milliwatts (mW) at 76 megahertz (MHZ) repetition rate. The galvanometer scanner of the BioRad laser scanning confocal microscope was used to direct the focused diffraction limited spot along a line about 600 microns long through a 0.5 or 0.75 NA 20 times magnification Zeiss Neofluor objective. To effect fabrication, the scan line was drawn and redrawn a minimum of about 100 times. The rod was fabricated quickly, in about 1-2 seconds. After fabrication, unreacted resin was removed from the structure by washing with ethanol and acetone. The sample was then air dried and sputter coated with 10 nm of AuPd in preparation for scanning electron microscopy.
Bovine serum albumin was dissolved in water to a concentration of 10 mg/mL. One mL of the BSA solution was then made about 1×10-4 in the photoinitiator Rose Bengal. This solution was then subjected to two-photon excitation as described in Example 1, resulting in polymerization. TEA may be present, but slows the reaction.
For three-photon excitation, the above solution was prepared, except for the substitution of Rose Bengal about 1 milligram (mg) of 9-fluorenone-2-carboxylic acid. Another aliquot of this solution was placed on a microscope slide on the stage, and a focused beam was scanned on the solution at a wavelength of 780 nm and pulse lengths of 100 femtoseconds. The galvanometer scanner of the BioRad laser scanning confocal microscope was used to direct the focused spot along a line about 600 microns long. A 0.5 NA 20X Zeiss Neofluor objective was used. Average power levels were 130 mW at 76 MHZ repetition rate, as measured without the objective lens in place, with an estimated energy loss through the objective of about 25 mW. Fabrication required the scan line to be drawn and redrawn a minimum of about 100 times, for a total dwell time required for optically visible fabrication of about 1-2 seconds The 780 nm wavelength represents a three-photon excitation of the fluorenone photoinitiator, which has a one-photon absorption maximum for the π→π* transition of about 270 nm. Upon excitation to the singlet state the fluorenone rapidly converts to the triplet state and initiates crosslinking via hydrogen abstraction. Two possible mechanisms are as follows:
(1) Fluorenone (triplet)+BSA→BSA•+H
BSA•+BSA→(BSA)2•
(BSA)2•+BSA→(BSA)3• etc.
(2) Fluorenone (triplet)+TEA→TEA•+H
TEA•+BSA→BSA•+TEA
BSA•+BSA→(BSA)2•
(BSA)2•+BSA→(BSA)3• etc.
The increased kinetic stability of the triethanolamine radical may contribute to increasing the efficiency of the crosslinking reaction.
Trimethylolpropane trimethacrylate (Aldrich) was made 1×10-5 in Rose Bengal, 0.1 M in triethanolamine, with about a drop of dimethyl sulfoxide (DMSO) added to enhance solubility. An acrylate polymer in the form of a pyramid (
Substitution of Rose Bengal with 2×10-5 9-fluorenone-2-carboxylic acid in the above reaction mixture resulted in polymerization upon treatment using three-photon excitation as described in Example 2. A lamellar structure formed by this method is shown in
A 40% aqueous solution comprising a ratio of acrylamide:bisacrylamide was made 1×10-4 in Rose Bengal and 0.1 M in triethanolamine. A polyacrylamide polymer in the form of a pyramid (
An aqueous solution comprising 5 mg/mL of fibrinogen and 1×10-4 Rose Bengal was polymerized using two-photon excitation as described in Example 1. Polymerization was also effected by two-photon excitation in the presence of Rose Bengal, but without triethanolamine.
Short term entrapment of an agent in a matrix fabricated by multi-photon excitation was illustrated with polyacrylamide gel/Rhodamine 610 and a BSA matrix/dextran. The polyacrylamide gel was formed by two-photon activation of a 17.5% aqueous solution containing a 29:1 ratio of acrylamide: bisacrylamide, 1×10-4M rose Bengal, 0.1 M triethanolomine, and loaded with 2×10-3 M Rhodamine 610. The formed gels were approximately 70 microns×100 micron×1.5 microns, and possessed different crosslink densities obtained by varying the irradiation time via the number of successive scans performed (50 and 75). The release of Rhodamine 610 was monitored optically by integration of the fluorescence intensity over the rectangular gels. As the data from two replicant experiments illustrated in
The BSA matrix was fabricated by two-photon activation of an aqueous solution comprising 10 mg/mL BSA, 1×10-4 rose Bengal, and loaded with 1×10-4M tetramethyl rhodamine labeled 10 kilodalton (kD) dextran (Molecular Probes, Eugene, OR). The rectangular BSA matrices were approximately 140 micron×175 micron×1.5 micron, and had different cross link densities due to using differing numbers of successive scans to form the matrix (5, 10, and 20). The release of 10 kD dextran was monitored optically by integration of the fluorescence intensity over the rectangular gels. Data from two replicant experiments is shown in
Permanent or long-term entrapment of a reactive agent such as an enzyme allows diffusion of a soluble reactant into a gel or construct, which is then acted upon by the entrapped agent. In this example, entrapment of alkaline phsophatase results in removal of a phosphate moiety from the soluble reactant. Alkaline phosphatase was chosen as a model enzyme since its activity may be readily assayed and spatially localized with fluorescence microscopy using an enzyme-linked fluorescence (ELF) reagent produced by Molecular Probes Inc. (B6601, Eugene, Oreg.). Upon cleavage of the phosphate group from the ELF reagent, its fluorescent emission wavelength changes, its fluorescent intensity greatly increased, and it became insoluble, thereby precipitating in the immediate vicinity of the active enzyme. Images were produced by excitation of the precipitated agent by 2-photon excitation fluorescence at about 825 nm.
Accordingly, alkaline phosphatase (Sigma P-0530) was incorporated into rectangular-polyacrylamide gels (134 micron×89 micron×1.5 micron) by two-photon excitation of a 40% aqueous solution of 29:1 acrylamide:bisacrylamide, comprising 1×10-4 rose Bengal, 0.1 M triethanolamine, and 2 micromolar bovine alkaline phosphatase. Varying the time of polymerization resulted in gels having different densities. One gel received 50 scans (total photon dose=2×1020 photons/cm2) and the another gel received 75 scans (photon dose=3×1020 photons/cm2), with this higher photon dose leading to a slightly larger polymerized area, due to oversaturation-induced decreased confinement of the two-photon excitation zone.
Encapsulation may also be accomplished with smaller constructs.
While preferred embodiments have been shown and described, various modifications and substitutions may be made thereto without departing from the spirit and scope of the invention. Accordingly, it is to be understood that the present invention has been described by way of illustration and not limitation.
Goodman, Steven L., Campagnola, Paul
Patent | Priority | Assignee | Title |
10094821, | Oct 06 2014 | Organovo, Inc. | Engineered renal tissues, arrays thereof, and methods of making the same |
10167447, | Dec 21 2012 | Zimmer, Inc. | Supports and methods for promoting integration of cartilage tissue explants |
10174276, | Apr 20 2012 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking |
10324080, | Nov 17 2015 | Purdue Research Foundation | Systems and methods for automated image-guided patch-clamp electrophysiology in vitro |
10400219, | Mar 15 2013 | Organovo, Inc. | Engineered liver tissues, arrays thereof, and methods of making the same |
10500581, | Mar 25 2003 | Crystaphase International, Inc. | Separation method and assembly for process streams in component separation units |
10525456, | Mar 25 2003 | Crystaphase International, Inc. | Separation method and assembly for process streams in component separation units |
10543483, | Mar 25 2003 | Crystaphase International, Inc. | Separation method and assembly for process streams in component separation units |
10557486, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10655654, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10662986, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10738806, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10744426, | Dec 31 2015 | CRYSTAPHASE PRODUCTS, INC.; CRYSTAPHASE PRODUCTS, INC | Structured elements and methods of use |
10876553, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10920807, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
10962526, | Oct 06 2014 | Organovo, Inc. | Engineered renal tissues, arrays thereof, and methods of making the same |
10967560, | Oct 21 2010 | Organovo, Inc. | Devices, systems, and methods for the fabrication of tissue |
11000785, | Dec 31 2015 | CRYSTAPHASE PRODUCTS, INC. | Structured elements and methods of use |
11052363, | Dec 20 2019 | CRYSTAPHASE PRODUCTS, INC. | Resaturation of gas into a liquid feedstream |
11059194, | Jun 30 2015 | The Gillette Company LLC | Polymeric cutting edge structures and method of manufacturing polymeric cutting edge structures |
11124774, | Mar 15 2013 | Organovo, Inc. | Engineered liver tissues, arrays thereof, and methods of making the same |
11156240, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
11384328, | Nov 18 2015 | President and Fellows of Harvard College | Cartridge-based system for long term culture of cell clusters |
11413805, | Oct 21 2010 | Organovo, Inc. | Bioprinter for the fabrication of tissue |
11518978, | Jun 24 2008 | The Curators of the University of Missouri | Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
11529436, | Nov 05 2014 | L Oreal | Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same |
11577450, | Oct 21 2010 | Organovo, Inc. | Methods for the fabrication of tissue via printing |
11577451, | Oct 21 2010 | Organovo, Inc. | Bioprinter for the fabrication of tissue |
11597112, | Jun 30 2015 | The Gillette Company LLC | Polymeric cutting edge structures and method of manufacturing polymeric cutting edge structures |
11629318, | Oct 20 2017 | President and Fellows of Harvard College | Methods for producing mature adipocytes and methods of use thereof |
11731095, | Dec 20 2019 | CRYSTAPHASE PRODUCTS, INC. | Resaturation of gas into a liquid feedstream |
11752477, | Sep 09 2020 | CRYSTAPHASE PRODUCTS, INC. | Process vessel entry zones |
11754100, | Feb 12 2016 | CRYSTAPHASE PRODUCTS, INC. | Use of treating elements to facilitate flow in vessels |
11789011, | Apr 04 2014 | Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model | |
11867689, | Oct 06 2014 | Organovo, Inc. | Engineered renal tissues, arrays thereof, and methods of making the same |
11886022, | Nov 06 2020 | SAMSUNG ELECTRONICS CO , LTD | Beam expander and beam expansion method |
7354733, | Mar 29 2001 | CELLECT TECHNOLOGIES CORP | Method for sorting and separating living cells |
7551359, | Sep 14 2006 | 3M Innovative Properties Company | Beam splitter apparatus and system |
7720533, | Dec 20 2006 | Zimmer Orthobiologicals, Inc.; ZIMMER ORTHOBIOLOGICS, INC | Apparatus and method for delivering a biocompatible material to a surgical site |
7811484, | Oct 02 2003 | Canon Kabushiki Kaisha | Apparatus for producing three-dimensional structure |
7893410, | Dec 21 2005 | 3M Innovative Properties Company | Method and apparatus for processing multiphoton curable photoreactive compositions |
8107168, | Sep 14 2006 | 3M Innovative Properties Company | Beam splitter apparatus and system |
8311788, | Jul 01 2009 | Schlumberger Technology Corporation | Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry |
8322874, | Sep 06 2007 | 3M Innovative Properties Company | Lightguides having light extraction structures providing regional control of light output |
8451457, | Oct 11 2007 | 3M Innovative Properties Company | Chromatic confocal sensor |
8455846, | Dec 12 2007 | 3M Innovative Properties Company | Method for making structures with improved edge definition |
8480757, | Aug 26 2005 | ZIMMER, INC | Implants and methods for repair, replacement and treatment of disease |
8497121, | Dec 20 2006 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
8518433, | Dec 11 2003 | ZIMMER, INC | Method of treating an osteochondral defect |
8524268, | Dec 11 2003 | ZIMMER, INC | Cadaveric allogenic human juvenile cartilage implant |
8545037, | Sep 06 2007 | 3M Innovative Properties Company | Lightguides having light extraction structures providing regional control of light output |
8605256, | Feb 26 2008 | 3M Innovative Properties Company | Multi-photon exposure system |
8652507, | Dec 11 2003 | ZIMMER, INC | Juvenile cartilage composition |
8725477, | Apr 10 2008 | Schlumberger Technology Corporation | Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics |
8748181, | May 23 2008 | President and Fellows of Harvard College | Methods of generating patterned soft substrates and uses thereof |
8765165, | Dec 11 2003 | ZIMMER, INC | Particulate cartilage system |
8784863, | Dec 11 2003 | ZIMMER, INC | Particulate cadaveric allogenic cartilage system |
8834914, | Dec 11 2003 | ZIMMER, INC | Treatment methods using a particulate cadaveric allogenic juvenile cartilage particles |
8885146, | Feb 26 2008 | 3M Innovative Properties Company | Multi-photon exposure system |
8908925, | Feb 28 2011 | Schlumberger Technology Corporation | Methods to build 3D digital models of porous media using a combination of high- and low-resolution data and multi-point statistics |
8939966, | Aug 21 2008 | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC | Differential laser-induced perturbation (DLIP) for bioimaging and chemical sensing |
9102083, | Sep 06 2007 | 3M Innovative Properties Company | Methods of forming molds and methods of forming articles using said molds |
9138318, | Apr 12 2007 | ZIMMER, INC | Apparatus for forming an implant |
9149952, | Oct 21 2010 | ORGANOVO, INC | Devices, systems, and methods for the fabrication of tissue |
9222932, | Mar 15 2013 | ORGANOVO, INC | Engineered liver tissues, arrays thereof, and methods of making the same |
9227339, | Oct 21 2010 | ORGANOVO, INC | Devices, systems, and methods for the fabrication of tissue |
9315043, | Jul 31 2013 | ORGANOVO, INC | Automated devices, systems, and methods for the fabrication of tissue |
9440376, | Sep 06 2007 | 3M Innovative Properties Company | Methods of forming molds and methods of forming articles using said molds |
9442105, | Mar 15 2013 | ORGANOVO, INC | Engineered liver tissues, arrays thereof, and methods of making the same |
9481868, | Oct 06 2014 | ORGANOVO, INC | Engineered renal tissues, arrays thereof, and methods of making the same |
9499779, | Apr 20 2012 | ORGANOVO, INC | Devices, systems, and methods for the fabrication of tissue utilizing UV cross-linking |
9556415, | Jun 24 2008 | The Curators of the University of Missouri | Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
9581723, | Apr 10 2008 | Schlumberger Technology Corporation | Method for characterizing a geological formation traversed by a borehole |
9752116, | Feb 24 2004 | The Curators of the University of Missouri; MUSC Foundation for Research Development | Self-assembling cell aggregates and methods of making engineered tissue using the same |
9855369, | Oct 21 2010 | Organovo, Inc. | Method of printing a three-dimensional structure |
9983195, | Apr 04 2014 | ORGANOVO, INC | Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model |
Patent | Priority | Assignee | Title |
4575330, | Aug 08 1984 | 3D Systems, Inc | Apparatus for production of three-dimensional objects by stereolithography |
5034613, | Nov 14 1989 | Cornell Research Foundation, Inc | Two-photon laser microscopy |
5113117, | Sep 08 1989 | Massachusetts Institute of Technology | Miniature electrical and mechanical structures useful for constructing miniature robots |
5289407, | Jul 22 1991 | CORNELL RESEARCH FOUNDATION, INC A CORP OF NEW YORK | Method for three dimensional optical data storage and retrieval |
5360764, | Feb 16 1993 | UNITED STATES OF AMERICA, THE, AS REPRESENTED BY NATIONAL INSTITUTES OF STANDARDS AND TECHNOLOGY | Method of fabricating laser controlled nanolithography |
5370692, | Aug 14 1992 | BIOZ, LLC | Rapid, customized bone prosthesis |
5380589, | Apr 19 1993 | Wisconsin Alumni Research Foundation | Biotextured surfaces |
5410016, | Oct 15 1990 | BOARD OF REGENTS UNIVERSITY OF TEXAS SYSTEM, THE | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
5518680, | Oct 18 1993 | Massachusetts Institute of Technology | Tissue regeneration matrices by solid free form fabrication techniques |
5556752, | Oct 24 1994 | AFFYMETRIX INC , A CORP OF DE | Surface-bound, unimolecular, double-stranded DNA |
5700241, | Apr 04 1996 | Wisconsin Alumni Research Foundation | Cross-sectional tissue textured surfaces |
5808256, | Dec 07 1993 | Rikagaku Kenkyusho | Method of controlling a photoreaction with a laser beam |
5849035, | Apr 28 1993 | Focal, Inc. | Methods for intraluminal photothermoforming |
5858746, | Apr 20 1992 | Board of Regents, The University of Texas System | Gels for encapsulation of biological materials |
5998597, | Oct 30 1996 | PROVECTUS DEVICETECH, INC | Method for improved selectivity in photo-activation of molecular agents |
6316153, | Apr 21 1998 | Univeristy of Connecticut | Free-form fabricaton using multi-photon excitation |
DE19628355, | |||
DE4309068, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Sep 05 2001 | The University of Connecticut | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Sep 28 2007 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Oct 08 2007 | REM: Maintenance Fee Reminder Mailed. |
Aug 08 2008 | STOL: Pat Hldr no Longer Claims Small Ent Stat |
Aug 31 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Jul 31 2015 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Mar 30 2007 | 4 years fee payment window open |
Sep 30 2007 | 6 months grace period start (w surcharge) |
Mar 30 2008 | patent expiry (for year 4) |
Mar 30 2010 | 2 years to revive unintentionally abandoned end. (for year 4) |
Mar 30 2011 | 8 years fee payment window open |
Sep 30 2011 | 6 months grace period start (w surcharge) |
Mar 30 2012 | patent expiry (for year 8) |
Mar 30 2014 | 2 years to revive unintentionally abandoned end. (for year 8) |
Mar 30 2015 | 12 years fee payment window open |
Sep 30 2015 | 6 months grace period start (w surcharge) |
Mar 30 2016 | patent expiry (for year 12) |
Mar 30 2018 | 2 years to revive unintentionally abandoned end. (for year 12) |